This Director Sold 42,000 Shares of Wave Life Sciences for $630,000. What Investors Should Know About This Biotech Company.

Wave Life Sciences is a clinical-stage biotechnology company focused on advancing stereopure oligonucleotide therapeutics for rare genetic diseases. The company leverages its PRISM platform and strategic partnerships to accelerate drug discovery and development across multiple therapeutic areas. Its differentiated approach and collaboration-driven model position it as an innovator within the genetic medicines sector .Operates a platform-based model leveraging proprietary PRISM technology to design and optim ...